Global Stem Cell Therapy Market Size study, By Cell Source (Adipose tissue-derived MSCs (mesenchymal stem cells), Bone marrow-derived MSCs, Placental/umbilical cord-derived MSCs, Other Cell Sources), By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Surgeries, Inflammatory & Autoimmune Diseases, Neurological Disorders, Other), and Regional Forecasts 2022-2028
- BIZ4950970
- 200 Pages
- March 2022
- Diagnostic and Biotech
Stem cells are cells with the ability to grow into various different forms of cells in both animal and human bodies. These cells are majorly served as a repair system for the body and are often used in medicine and surgery. Stem cell therapy is also commonly called centerpiece therapy or regenerative medicine. Regenerative medications have the potential to revive cells and replace those that have been damaged or died. This cell therapy is used to treat a variety of chronic conditions, involves blood and cancer disorders. The growing prevalence of chronic disorders, availability of funding for stem cell research, increasing number of approvals for cell therapy production facilities, coupled with the rising clinical trials for stem cell based-therapies are the primary factors that may surge the market demand across the globe. For instance, in September 2020, Stemedica Cell Technologies get investigational new drug (IND) approval by the US FDA for the its intravenous allogeneic mesenchymal stem cells (MSCs) for curing moderate to severe COVID-19 patients. Moreover, increasing initiatives by the public and private organizations to spread awareness and development in medical technology, along with rising government investments in healthcare facilities are further factors, which, in turn, surge the global market demand. However, the high cost of cell-based research and ethical concerns associated with the embryonic stem cells impede the growth of the market over the forecast period of 2022-2028. Also, growing demand for cell & gene therapies and the emergence of induced pluripotent stem cells (iPSCs) as an alternative to Embryonic stem cells (ESCs) are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Stem Cell Therapy Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the increasing number of clinical trials and growing public-private funding and research grants for evolving safe & effective stem cell therapy products. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as increasing government support, growing investment in the healthcare sector, as well an escalating patient pool, would create lucrative growth prospects for the Stem Cell Therapy Market across the Asia-Pacific region.
Major market players included in this report are:
MEDIPOST
Anterogen
Regrow Biosciences
Stempeutics Research
CORESTEM
PHARMICELL
NuVasive
RTI Surgical
AlloSource
JCR Pharmaceuticals
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Cell Source
Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),
Bone Marrow-Derived Mscs,
Placental/Umbilical Cord-Derived Mscs, And
Other Cell Sources
By Type
Allogeneic Stem Cell Therapy
Autologous Stem Cell Therapy
By Therapeutic Application
Musculoskeletal Disorders
Wounds & Injuries,
Cardiovascular Diseases
Surgeries,
Inflammatory & Autoimmune Diseases
Neurological Disorders,
Other
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Stem Cell Therapy Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Global Stem Cell Therapy Market, by Region, 2020-2028 (USD Million)
1.2.2. Global Stem Cell Therapy Market, by Cell Source, 2020-2028 (USD Million)
1.2.3. Global Stem Cell Therapy Market, by Type, 2020-2028 (USD Million)
1.2.4. Global Stem Cell Therapy Market, by Therapeutic Application, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Stem Cell Therapy Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Stem Cell Therapy Market Dynamics
3.1. Stem Cell Therapy Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising number of GMP-certification approvals for cell therapy production facilities
3.1.1.2. Increasing clinical trials for stem cell based-therapies
3.1.2. Market Challenges
3.1.2.1. High cost of cell-based research
3.1.2.2. Ethical concerns related to embryonic stem cells
3.1.3. Market Opportunities
3.1.3.1. The emergence of iPSCs as an alternative to ESCs
3.1.3.2. Increasing demand for cell & gene therapies
Chapter 4. Global Stem Cell Therapy Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2019-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Stem Cell Therapy Market, by Cell Source
6.1. Market Snapshot
6.2. Global Stem Cell Therapy Market by Cell Source, Performance - Potential Analysis
6.3. Global Stem Cell Therapy Market Estimates & Forecasts by Cell Source 2019-2028 (USD Million)
6.4. Stem Cell Therapy Market, Sub Segment Analysis
6.4.1. Adipose Tissue-Derived Mscs (Mesenchymal Stem Cells),
6.4.2. Bone Marrow-Derived Mscs,
6.4.3. Placental/Umbilical Cord-Derived Mscs, And
6.4.4. Other Cell Sources
Chapter 7. Global Stem Cell Therapy Market, by Type
7.1. Market Snapshot
7.2. Global Stem Cell Therapy Market by Type, Performance - Potential Analysis
7.3. Global Stem Cell Therapy Market Estimates & Forecasts by Type 2019-2028 (USD Million)
7.4. Stem Cell Therapy Market, Sub Segment Analysis
7.4.1. Allogeneic Stem Cell Therapy
7.4.2. Autologous Stem Cell Therapy
Chapter 8. Global Stem Cell Therapy Market, by Therapeutic Application
8.1. Market Snapshot
8.2. Global Stem Cell Therapy Market by Therapeutic Application, Performance - Potential Analysis
8.3. Global Stem Cell Therapy Market Estimates & Forecasts by Therapeutic Application 2019-2028 (USD Million)
8.4. Stem Cell Therapy Market, Sub Segment Analysis
8.4.1. Musculoskeletal Disorders
8.4.2. Wounds & Injuries,
8.4.3. Cardiovascular Diseases
8.4.4. Surgeries,
8.4.5. Inflammatory & Autoimmune Diseases
8.4.6. Neurological Disorders,
8.4.7. Other
Chapter 9. Global Stem Cell Therapy Market, Regional Analysis
9.1. Stem Cell Therapy Market, Regional Market Snapshot
9.2. North America Stem Cell Therapy Market
9.2.1. U.S. Stem Cell Therapy Market
9.2.1.1. Cell Source estimates & forecasts, 2019-2028
9.2.1.2. Type estimates & forecasts, 2019-2028
9.2.1.3. Therapeutic Application estimates & forecasts, 2019-2028
9.2.2. Canada Stem Cell Therapy Market
9.3. Europe Stem Cell Therapy Market Snapshot
9.3.1. U.K. Stem Cell Therapy Market
9.3.2. Germany Stem Cell Therapy Market
9.3.3. France Stem Cell Therapy Market
9.3.4. Spain Stem Cell Therapy Market
9.3.5. Italy Stem Cell Therapy Market
9.3.6. Rest of Europe Stem Cell Therapy Market
9.4. Asia-Pacific Stem Cell Therapy Market Snapshot
9.4.1. China Stem Cell Therapy Market
9.4.2. India Stem Cell Therapy Market
9.4.3. Japan Stem Cell Therapy Market
9.4.4. Australia Stem Cell Therapy Market
9.4.5. South Korea Stem Cell Therapy Market
9.4.6. Rest of Asia Pacific Stem Cell Therapy Market
9.5. Latin America Stem Cell Therapy Market Snapshot
9.5.1. Brazil Stem Cell Therapy Market
9.5.2. Mexico Stem Cell Therapy Market
9.6. Rest of The World Stem Cell Therapy Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. MEDIPOST
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Anterogen
10.2.3. Regrow Biosciences
10.2.4. Stempeutics Research
10.2.5. CORESTEM
10.2.6. PHARMICELL
10.2.7. NuVasive
10.2.8. RTI Surgical
10.2.9. AlloSource
10.2.10. JCR Pharmaceuticals
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Stem Cell Therapy Market, report scope
TABLE 2. Global Stem Cell Therapy Market estimates & forecasts by Region 2019-2028 (USD Million)
TABLE 3. Global Stem Cell Therapy Market estimates & forecasts by Cell Source 2019-2028 (USD Million)
TABLE 4. Global Stem Cell Therapy Market estimates & forecasts by Type 2019-2028 (USD Million)
TABLE 5. Global Stem Cell Therapy Market estimates & forecasts by Therapeutic Application 2019-2028 (USD Million)
TABLE 6. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 7. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 8. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 9. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 10. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 11. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 12. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 13. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 14. Global Stem Cell Therapy Market by segment, estimates & forecasts, 2019-2028 (USD Million)
TABLE 15. Global Stem Cell Therapy Market by region, estimates & forecasts, 2019-2028 (USD Million)
TABLE 16. U.S. Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 17. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 18. U.S. Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 19. Canada Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 20. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 21. Canada Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 22. UK Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 23. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 24. UK Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 25. Germany Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 26. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 27. Germany Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 28. RoE Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 29. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 30. RoE Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 31. China Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 32. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 33. China Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 34. India Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 35. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 36. India Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 37. Japan Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 38. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 39. Japan Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 40. RoAPAC Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 41. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 42. RoAPAC Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 43. Brazil Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 44. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 45. Brazil Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 46. Mexico Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 47. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 48. Mexico Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 49. RoLA Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 50. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 51. RoLA Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 52. Row Stem Cell Therapy Market estimates & forecasts, 2019-2028 (USD Million)
TABLE 53. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 54. Row Stem Cell Therapy Market estimates & forecasts by segment 2019-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Stem Cell Therapy Market
TABLE 56. List of primary sources, used in the study of global Stem Cell Therapy Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Similar Reports
Complete report $6,100. DataPack (test volumes, sales forecasts, supplier shares) $3,950.
Summary
This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...
- Publish Date: February 7, 2017
- $750
Complete report $9,600. DataPack (test volumes, sales forecasts, supplier shares) $6,200.
Summary
This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...
- Publish Date: February 7, 2017
- $750
This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Con...
- Publish Date: February 7, 2017
- $750
